These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 21888897)
21. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene]. Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350 [TBL] [Abstract][Full Text] [Related]
22. The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. Li Z; Wang D; Na X; Schoen SR; Messing EM; Wu G EMBO J; 2003 Apr; 22(8):1857-67. PubMed ID: 12682018 [TBL] [Abstract][Full Text] [Related]
23. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related]
24. VHL and HIF signalling in renal cell carcinogenesis. Baldewijns MM; van Vlodrop IJ; Vermeulen PB; Soetekouw PM; van Engeland M; de Bruïne AP J Pathol; 2010 Jun; 221(2):125-38. PubMed ID: 20225241 [TBL] [Abstract][Full Text] [Related]
26. [HIF-1alpha, HIF-2alpha and VHL mRNA expression in different cell lines during hypoxia]. Bobarykina AIu; Minchenko DO; Opentanova IL; Kovtun OO; Komisarenko SV; Esumi H; Minchenko OH Ukr Biokhim Zh (1999); 2006; 78(2):62-72. PubMed ID: 17100286 [TBL] [Abstract][Full Text] [Related]
27. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
28. HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells. Nauta TD; Duyndam MC; Weijers EM; van Hinsbergh VM; Koolwijk P PLoS One; 2016; 11(8):e0160700. PubMed ID: 27490118 [TBL] [Abstract][Full Text] [Related]
29. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses. Yoon H; Shin SH; Shin DH; Chun YS; Park JW Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936 [TBL] [Abstract][Full Text] [Related]
30. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297 [TBL] [Abstract][Full Text] [Related]
31. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Liu MY; Poellinger L; Walker CL Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296 [TBL] [Abstract][Full Text] [Related]
32. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
33. Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation. Chen L; Uchida K; Endler A; Shibasaki F J Biol Chem; 2007 Apr; 282(17):12707-16. PubMed ID: 17324924 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077 [TBL] [Abstract][Full Text] [Related]
35. Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma. Wright TM; Rathmell WK J Biol Chem; 2010 Apr; 285(17):12916-24. PubMed ID: 20185829 [TBL] [Abstract][Full Text] [Related]
36. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
37. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner. Kai S; Tanaka T; Daijo H; Harada H; Kishimoto S; Suzuki K; Takabuchi S; Takenaga K; Fukuda K; Hirota K Antioxid Redox Signal; 2012 Feb; 16(3):203-16. PubMed ID: 22004513 [TBL] [Abstract][Full Text] [Related]
38. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function. Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953 [TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of the Prox1 gene by HIF-1α and HIF-2α in response to hypoxia. Zhou B; Si W; Su Z; Deng W; Tu X; Wang Q FEBS Lett; 2013 Mar; 587(6):724-31. PubMed ID: 23395615 [TBL] [Abstract][Full Text] [Related]
40. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI; Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]